Cargando…

Angiopoietin‐2 and hemocompatibility‐related adverse events during percutaneous left ventricular assist device supports

Detalles Bibliográficos
Autores principales:	Imamura, Teruhiko, Nakamura, Makiko, Yokoyama, Shigeki, Doi, Toshio, Fukahara, Kazuaki, Kinugawa, Koichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714272/ https://www.ncbi.nlm.nih.gov/pubmed/33305013 http://dx.doi.org/10.1002/hsr2.211

Ejemplares similares

A case of cardiogenic shock due to acute coronary syndrome successfully recovered by percutaneous and paracorporeal left ventricular assist device
por: Nakamura, Makiko, et al.
Publicado: (2019)

A Rescue Use of ECPELLA for Sepsis-Induced Cardiogenic Shock Followed by Mitral Valve Replacement
por: Nakamura, Makiko, et al.
Publicado: (2022)

Successful Management of Pheochromocytoma Crisis with Cardiogenic Shock by Percutaneous Left Ventricular Assist Device
por: Nakamura, Makiko, et al.
Publicado: (2022)

Hemocompatibility-related Adverse Events Following HeartMate II Left Ventricular Assist Device Implantation between Japan and United States
por: Imamura, Teruhiko, et al.
Publicado: (2020)

Percutaneous transseptal transcatheter mitral valve-in-valve replacement for degenerated mitral bioprosthesis: The first experience in Japan
por: Ueno, Hiroshi, et al.
Publicado: (2020)

Trans-Apical Transcatheter Aortic Valve Replacement in a Dialysis Patient with Systolic Heart Failure
por: Oshima, Akira, et al.
Publicado: (2022)

Acute Heart Failure in a Patient with Occult Barlow’s Disease Receiving Bevacizumab
por: Izumida, Toshihide, et al.
Publicado: (2021)

Effect of add-on sacubitril/valsartan on the left ventricular hypertrophy of a patient with hypertension
por: Imamura, Teruhiko, et al.
Publicado: (2022)

Bail-out Ablation of Ventricular Tachycardia Electrical Storm in a Patient with a Durable Left Ventricular Assist Device
por: Izumida, Toshihide, et al.
Publicado: (2022)

Arrhythmogenic Right Ventricular Cardiomyopathy Accompanied by Chronic Myocarditis
por: Nakamura, Makiko, et al.
Publicado: (2022)

Initial Experience of Vericiguat Treatment in Patients with Heart Failure and Reduced Ejection Fraction
por: Nakamura, Makiko, et al.
Publicado: (2023)

Decoupling Between Diastolic Pulmonary Artery and Pulmonary Capillary Wedge Pressures Is Associated With Right Ventricular Dysfunction and Hemocompatibility‐Related Adverse Events in Patients With Left Ventricular Assist Devices
por: Imamura, Teruhiko, et al.
Publicado: (2020)

Primary Cardiac Angiosarcoma Accompanying Cardiac Tamponade
por: Hori, Masakazu, et al.
Publicado: (2021)

Implication of Ivabradine in Up-titrating Beta-blocker in a Patient with Advanced Heart Failure
por: Hori, Masakazu, et al.
Publicado: (2020)

Initial Real-World Practical Experience of Sacubitril/Valsartan Treatment in Japanese Patients With Chronic Heart Failure
por: Nakamura, Makiko, et al.
Publicado: (2021)

Impact of the Severity of Acquired von Willebrand Syndrome on the Short-Term Prognosis in Patients with Temporary Mechanical Circulatory Support
por: Nakamura, Makiko, et al.
Publicado: (2022)

Pulmonary Artery Pulsatility Index and Hemolysis during Impella-Incorporated Mechanical Circulatory Support
por: Nakamura, Makiko, et al.
Publicado: (2022)

Optimal Heart Rate and Prognosis in Patients with Cardiac Amyloidosis
por: Izumida, Toshihide, et al.
Publicado: (2021)

Prognostic Impact of the Increase in Cardiac Troponin Levels during Tafamidis Therapy in Patients with Transthyretin Cardiac Amyloidosis
por: Nakamura, Makiko, et al.
Publicado: (2023)

Concomitant septal myectomy and mitral valve repair in a child with Noonan syndrome
por: Doi, Toshio, et al.
Publicado: (2020)

Initial report of percutaneous left atrial appendage closure in hemodialysis patients with atrial fibrillation and high risk of bleeding in Japan
por: Ueno, Hiroshi, et al.
Publicado: (2022)

Iatrogenic diversion of the inferior vena cava into the left atrium diagnosed 43 years after surgical atrial septal defect closure
por: Doi, Toshio, et al.
Publicado: (2021)

Constipation as a Drug-Related Adverse Effect in Patients with Hyperkalemia: Sodium Zirconium Cyclosilicate versus Conventional Potassium Binders
por: Hida, Yuki, et al.
Publicado: (2023)

Predictors and Outcomes of SGLT2 Inhibitor Discontinuation in a Real-World Population after Hospitalization for Heart Failure
por: Nakagaito, Masaki, et al.
Publicado: (2023)

Mid-Term Feasibility of Percutaneous Left Atrial Appendage Occlusion in Elderly Patients with Non-Valvular Atrial Fibrillation
por: Fukuda, Nobuyuki, et al.
Publicado: (2023)

Patient Selection for Pemafibrate Therapy to Prevent Adverse Cardiovascular Events
por: Izumida, Toshihide, et al.
Publicado: (2022)

Remote Dielectric Sensing to Assess Residual Pulmonary Congestion Following Percutaneous Mitral Valve Repair
por: Imamura, Teruhiko, et al.
Publicado: (2022)

Sex-Related Differences in Short-Term Prognosis in Patients with Acute Myocardial Infarction-Related Cardiogenic Shock Receiving Impella Support in Japan: From the J-PVAD Registry
por: Nakamura, Makiko, et al.
Publicado: (2023)

Takayasu Arteritis Complicated by Ischemic Colitis: A Case Report
por: Yamashita, Shigeyuki, et al.
Publicado: (2022)

Mitral valve plasty in a patient with multiple cerebral cavernous malformations: A case report
por: Yamashita, Shigeyuki, et al.
Publicado: (2022)

Comparison in Short-Term Safety and Efficacy between New-Generation WATCHMAN FLX and Conventional WATCHMAN 2.5 for Percutaneous Left Atrial Appendage Closure
por: Fukuda, Nobuyuki, et al.
Publicado: (2022)

Initial Experience With Tafamidis Treatment for Transthyretin Amyloid Cardiomyopathy
por: Nakamura, Makiko, et al.
Publicado: (2020)

Renoprotective effects of sodium glucose cotransporter 2 inhibitors in type 2 diabetes patients with decompensated heart failure
por: Nakagaito, Masaki, et al.
Publicado: (2021)

Factors Associated with Recurrent Heart Failure during Incorporating SGLT2 Inhibitors in Patients Hospitalized for Acute Decompensated Heart Failure
por: Nakagaito, Masaki, et al.
Publicado: (2022)

Comparison of the Hemocompatibility of an Axial and a Centrifugal Left Ventricular Assist Device in an In Vitro Test Circuit
por: Borchers, Patrick, et al.
Publicado: (2022)

Practical Therapeutic Management of Percutaneous Atrial Septal Defect Closure
por: Tanaka, Shuhei, et al.
Publicado: (2021)

Preoperative risk factors of early right ventricular failure—following left ventricular assist device implantation
por: Imamura, Teruhiko
Publicado: (2020)

Optimal echocardiographic ramp testing during left ventricular assist device supports
por: Imamura, Teruhiko
Publicado: (2020)

Optimal therapeutic strategy using durable left ventricular assist device in Korea
por: Imamura, Teruhiko
Publicado: (2021)

Urine Aquaporin-2: A Promising Marker of Response to the Arginine Vasopressin Type-2 Antagonist, Tolvaptan in Patients with Congestive Heart Failure
por: Imamura, Teruhiko, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_di3coej123bqpqubpu6arsk1o5